Catalyst Wire Dossier Catalyst Wire Dossier

Invanz (ertapenem)

ertapenem · Merck & Co.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Invanz (ertapenem), covering 2011-08-09 to 2014-04-03. Get the full timeline:

Most recent: Clinical Trial Update: An Observational Study of Ertapenem in Outpatient Parenteral Antibiotic Therapy (OPAT) for Complicated Urinary Tract Infections.

See pricing